Cue Biopharma (CUE) Prepaid Assets (2017 - 2025)

Cue Biopharma has disclosed Prepaid Assets across 9 years of filings, most recently posting $1.3 million for Q4 2025.

• Prepaid Assets for Q4 2025 came in at $1.3 million, up 62.61% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.3 million (up 62.61% YoY), and the FY2025 annual result was $1.3 million, up 62.61% from the prior year.
• Prepaid Assets came in at $1.3 million for Q4 2025 at Cue Biopharma, down from $3.1 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $3.1 million in Q3 2025 to a low of $160000.0 in Q2 2021.
• The 5-year median for Prepaid Assets is $1.9 million (2021), against an average of $1.7 million.
• Across the five-year window, Prepaid Assets soared 1238.75% in 2022 and sank 32.31% in 2023, its largest moves.
• Cue Biopharma's Prepaid Assets stood at $954792.0 in 2021, then decreased by 11.92% to $841000.0 in 2022, then climbed by 13.56% to $955000.0 in 2023, then slipped by 15.71% to $805000.0 in 2024, then jumped by 62.61% to $1.3 million in 2025.
• The last three Prepaid Assets figures came in at $1.3 million (Q4 2025), $3.1 million (Q3 2025), and $2.4 million (Q2 2025), per Business Quant data.